Company Overview and News

 
Boeing signs maintenance deals with El Al Airlines, Lufthansa

2h financialexpress
Boeing Co signed a two-year maintenance deal with Israel’s El Al Airlines on Wednesday, as it looks to boost its high-margin after-sales business that services planes bought by airlines and military customers. In addition, the world’s biggest planemaker supplemented an existing contract with Germany’s Lufthansa for the overhaul and exchange of landing gears for two 777-200F aircraft.
BOE BA

 
Boeing signs maintenance deals with El Al Airlines, Lufthansa

2h channelnewsasia
Boeing Co signed a two-year maintenance deal with Israel's El Al Airlines on Wednesday, as it looks to boost its high-margin after-sales business that services planes bought by airlines and military customers.
BOE BA

 
Boeing, ALC, Deliver S7 Airlines' First 737 MAX

2018-10-16 asdnews
Boeing [NYSE: BA], Air Lease Corp. [NYSE: AL; "ALC"], and S7 Airlines celebrated the delivery of the airline's first 737 MAX, via lease from ALC. S7, operated by Globus Airlines, becomes the first Russian airline to fly the new and improved 737 airplane. S7 plans to take 10 more 737 MAX jets over the next few years as part of its strategic plan to strengthen its airplane fleet.
AL ALLLZ BOE BA

 
Boeing Delivers SpiceJet's 1st 737 MAX Airplane

2018-10-16 asdnews
Boeing [NYSE: BA] and SpiceJet celebrated the delivery of the carrier's first 737 MAX 8. The airline plans to use the 737 MAX to expand and standardize its fleet, while leveraging the super-efficient jet to reduce fuel costs per airplane by $1.5 million a year.
BOE BA

2
Encouraging September Traffic Results From Southwest Ahead Of Third Quarter Earnings

2018-10-15 seekingalpha
Southwest Airlines reported year-over-year September 2018 traffic with revenue passenger miles and available seat miles increasing 5.3% and 6.8%, respectively.
JAPSY C6L AIR HA JBLU SINGY ANZFY AIZ ANZLY BOE ANZFF BA DAL SINGF

 
Dreamliner Cash Improvement Continues

2018-10-15 seekingalpha
Boeing (NYSE:BA) will be reporting its Q3 earnings on October 24th before the opening bell. On that day, the company also provides the deferred production balance of the Boeing 787. AeroAnalysis deems the development of the deferred production balance and unamortized tooling and other non-recurring costs interesting to follow, since it directly impacts the free cash flow of The Boeing Company and we view the Boeing 787 program as one of the key drivers for earnings and cash flow growth going forward.
BOE BA

 
Boeing: Any Potential Turbulence From Its Highly Leveraged Capital Structure?

2018-10-15 seekingalpha
Boeing has leveraged its capital structure ever further over the years through continued share buybacks, on top of the ongoing, equity-reducing pension liability adjustments that fund the company's pension benefits.
BOE BA

26
6 Most Important Things In Business Today–Sears Chapter 11

2018-10-15 247wallst
Sears Holdings Corp filed for Chapter 11 bankruptcy on Monday with a plan to close 142 more stores, throwing into doubt the future of the century-old retailer that once dominated U.S. malls but has withered in the age of internet shopping.
CCF SHLD GS GLSSP BOE JBK F GSC TFG MA GSJ JPM SNE SHLDW HRS GJS BA

 
Orbital up on FY19 guidance, new agreement

2018-10-15 businessnews.com.au
Shares in Orbital Corporation jumped 16 per cent today, after the local tech company announced a contract extension with multinational The Boeing Company and provided revenue guidance of $24 million for the 2019 financial year.
BOE BA OBTEF

 
Mumbai: Air India crew member falls off aircraft while boarding, hospitalised with injuries

2018-10-15 financialexpress
The incident happened on Air India flight AI 864 operating on Mumbai-Delhi route. During pre-boarding, the woman crew member, Harsha Lobo, went to open the L5 door of the Boeing 777 to allow the step ladder to align with the door. But there was a gap and while opening the door, she slipped and fell onto the tarmac, Times Of India reported.
BOE BA

 
Embraer launches longer-range private jets in turnaround push

2018-10-14 channelnewsasia
Embraer SA is adding two longer-range business jet variants to its mid-sized Legacy line featuring revamped cabins and technology that reduces turbulence to create smoother flights, the Brazilian plane maker said on Sunday.
BOE BA

 
Embraer launches longer-range private jets in turnaround push

2018-10-14 reuters
ORLANDO, Fla. (Reuters) - Embraer SA (EMBR3.SA) is adding two longer-range business jet variants to its mid-sized Legacy line, featuring revamped cabins and technology that reduces turbulence to create smoother flights, the Brazilian plane maker said on Sunday.
BOE BA

 
Embraer launches longer-range midsized private jets in turnaround push

2018-10-14 channelnewsasia
Embraer SA is adding two longer-range business jet variants to its mid-sized Legacy line featuring revamped cabins and technology that reduces turbulence to create smoother flights, the Brazilian plane maker said on Sunday.
BOE BA

 
Embraer launches longer-range midsized private jets in turnaround push

2018-10-14 reuters
ORLANDO, Fla. (Reuters) - Embraer SA is adding two longer-range business jet variants to its mid-sized Legacy line featuring revamped cabins and technology that reduces turbulence to create smoother flights, the Brazilian plane maker said on Sunday.
BOE BA

38
9 Dow Components Up by Double Digits

2018-10-14 247wallst
Last week was not a good one for equities. Even Friday’s partial recovery left behind a loss of 4.2% for the Dow industrials, 4% for the S&P 500, and 3.2% for the Nasdaq Composite. For the year to date, the Dow is up just 2.1%, trailing both the S&P 500 (up 2.6%) and the Nasdaq Composite (up 7%).
PFZ PFIZER V NKE MRK BOE AAPL CSCO MSFT BA 500680 PFE UNH DIS CSCOI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to LSE:BOE / BOEING CO on message board site Silicon Investor.

Boeing keeps setting new highs! When will it split? Boeing keeps setting new highs! When will it split? Boeing keeps setting new highs! When will it split? BA: Boeing Company BA: Boeing Company BA: Boeing Company
PKS Buyout of BA Six Flags buys Boeing - Thoughts? PKS Buyout of BA Six Flags buys Boeing - Thoughts? PKS Buyout of BA Six Flags buys Boeing - Thoughts? Boeing - Crisis?, What Crisis?! Boeing - Crisis?, What Crisis?! Boeing - Crisis?, What Crisis?!
Boeing, McDonnell Douglas and Fields Aircraft Spares Boeing, McDonnell Douglas and Fields Aircraft Spares Boeing, McDonnell Douglas and Fields Aircraft Spares Boeing and Fields Aircraft Spares (FASI) Boeing and Fields Aircraft Spares (FASI) Boeing and Fields Aircraft Spares (FASI)